DBV Technologies S.A. ADR buy melinda
Start price
19.11.18
/
50%
€14.52
Target price
22.01.19
€16.42
Performance (%)
-59.69%
End price
22.01.19
€5.85
Summary
This prediction ended on 22.01.19 with a price of €5.85. The BUY prediction by melinda for DBV Technologies S.A. ADR performed very badly with a performance of -59.69%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| DBV Technologies S.A. ADR | 8.092% | 8.092% | -76.770% | -92.808% |
| iShares Core DAX® | -0.205% | 2.949% | 17.330% | 18.203% |
| iShares Nasdaq 100 | 1.613% | 5.877% | 37.451% | 56.281% |
| iShares Nikkei 225® | -0.740% | -1.256% | 11.847% | 5.531% |
| iShares S&P 500 | 0.267% | 3.240% | 29.308% | 46.371% |
Comments by melinda for this prediction
In the thread DBV Technologies S.A. ADR diskutieren
Agenda 11/03 Publication de résultats
Develops non invasive epicutaneous diagnostics systems and immunotherapy for allergy diagnostics
DBV Technologies SA is a clinical-stage biopharmaceutical company, which deals with conducting of research and development of epicutaneous immunotherapy products.
It focuses on developing a novel technology platform called Viaskin, which is an electrostatic patch that offers a convenient, self-administered, non-invasive immunotherapy to patients.
The company has designed two products candidates: Viaskin Peanut and Viaskin Milk.
DBV Technologies was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.
DBV Technologies SA is a clinical-stage biopharmaceutical company, which deals with conducting of research and development of epicutaneous immunotherapy products.
It focuses on developing a novel technology platform called Viaskin, which is an electrostatic patch that offers a convenient, self-administered, non-invasive immunotherapy to patients.
The company has designed two products candidates: Viaskin Peanut and Viaskin Milk.
DBV Technologies was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.
Nombre d'employés : 242 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for DBV Technologies S.A. ADR
DBV Technologies S.A. ADR
Start price
Target price
Perf. (%)
€1.26
23.12.22
23.12.22
-
23.12.23
23.12.23
-48.81%
24.12.23
24.12.23
DBV Technologies S.A. ADR
Start price
Target price
Perf. (%)
€8.65
04.06.19
04.06.19
€16.24
04.11.21
04.11.21
-76.99%
04.01.21
04.01.21
DBV Technologies S.A. ADR
Start price
Target price
Perf. (%)
€8.01
04.04.19
04.04.19
€9.02
26.04.19
26.04.19
12.77%
26.04.19
26.04.19
DBV Technologies S.A. ADR
Start price
Target price
Perf. (%)
€20.62
27.04.18
27.04.18
€21.74
14.05.18
14.05.18
5.47%
14.05.18
14.05.18
DBV Technologies S.A. ADR
Start price
Target price
Perf. (%)
€31.90
27.01.17
27.01.17
€33.37
06.03.17
06.03.17
5.86%
06.03.17
06.03.17